Basic Information
ID: ALA650169
Type: Binding
Description: Inhibitory activity of compound against HIV-1 aspartyl protease.
Format: BAO_0000357
Organism: Human immunodeficiency virus 1
Target: Human immunodeficiency virus type 1 protease(ALA243)
Document: ALA1134992
Inhibitory activity of compound against HIV-1 aspartyl protease.: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA650169
Ki
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 612.68 | 4.57 | 4.57 |
| 648.66 | 4.85 | 4.85 |
| 612.68 | 4.57 | 4.57 |
| 576.70 | 4.30 | 4.30 |
| 416.52 | 3.89 | 3.89 |
| 540.67 | 5.84 | 5.84 |
| 559.71 | 5.86 | 5.86 |
| 578.67 | 5.49 | 5.49 |
| 550.70 | 5.08 | 5.08 |
| 574.72 | 6.50 | 6.50 |
| 576.65 | 6.12 | 6.12 |
| 512.65 | 4.40 | 4.40 |
| 606.73 | 4.50 | 4.50 |
| 678.69 | 5.05 | 5.05 |
| 576.65 | 6.12 | 6.12 |
| 548.69 | 4.78 | 4.78 |
| 560.70 | 5.14 | 5.14 |
| 440.55 | 4.06 | 4.06 |
| 310.40 | 2.27 | 2.27 |
| 530.67 | 5.55 | 5.55 |
| 443.52 | 4.20 | 4.20 |
| 415.54 | 3.77 | 3.77 |
| 461.54 | 3.42 | 3.42 |
| 443.55 | 3.28 | 3.28 |
| 425.53 | 4.06 | 4.06 |
| 602.70 | 5.54 | 5.54 |
| 600.73 | 5.02 | 5.02 |
| 545.69 | 5.56 | 5.56 |
| 545.69 | 5.56 | 5.56 |
| 545.69 | 5.56 | 5.56 |
| 563.70 | 4.77 | 4.77 |
| 545.69 | 5.56 | 5.56 |
| 533.65 | 6.11 | 6.11 |
| 415.54 | 3.77 | 3.77 |
| 533.65 | 6.11 | 6.11 |
| 440.55 | 4.06 | 4.06 |
| 455.56 | 3.64 | 3.64 |
| 458.56 | 3.28 | 3.28 |
| 598.75 | 6.47 | 6.47 |
| 570.70 | 5.85 | 5.85 |
| 570.70 | 5.85 | 5.85 |
| 622.77 | 6.88 | 6.88 |
| 400.52 | 4.19 | 4.19 |
| 556.66 | 5.54 | 5.54 |
| 556.66 | 5.54 | 5.54 |
| 520.68 | 5.26 | 5.26 |
| 742.93 | 7.52 | 7.52 |
| 758.92 | 8.01 | 8.01 |
| 642.71 | 4.77 | 4.77 |
| 584.71 | 6.46 | 6.46 |
| 642.71 | 4.77 | 4.77 |